A service of StreetInsider.com
Ticker Symbol

Most Popular

AAPL 524.94
GOOG 536.10
MSFT 40.01
BAC 16.15
FB 58.94

Recently Added

STLY 2.78
GUID 9.30
ICFI 39.41
NCIT 10.12
CUB 49.57

Gaining Speed

ABX 17.98
GOLD 78.70
GLOG 28.04
GG 23.60
ISRG 411.99

ZIOPHARM (ZIOP) Starts ZIO-201 Phase 2 in Germ Cell Tumors

ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) announced the start of a multicenter, single arm Phase 2 investigator-sponsored study of palifosfamide (ZIO-201) in patients with recurrent metastatic germ cell (testicular and ovarian) tumors who have relapsed on initial platinum-based therapy and high dose chemotherapy, or patients who are not eligible for...

Read More




Get Alerted When News Hits On This Stock - FREE!